Preventing Post-Vaccination Presyncope and Syncope in Adolescents Using Simple, Clinic-based Interventions: A Pilot Study

Completed · Not applicable

Conditions studied: Syncope, Vasovagal

In brief

This is a randomized controlled open-label trial. During the study, adolescents scheduled to receive at least one intramuscular (IM) vaccine will receive either Buzzy®, Music, or Buzzy® and Music intervention(s) in addition to standard care to evaluate the feasibility and acceptability of these interventions prior to being used in a larger study to assess the effectiveness of the interventions in preventing post-vaccination presyncope and syncope. Feasibility will be assessed according to study staff ability to successfully administer the protocol specified clinic-based interventions and per both study staff and healthcare provider responses to written feasibility assessments. Acceptability will be assessed according to the participant's self-report. In addition, baseline needle phobia and anxiety, post-vaccination pain and presyncope symptoms, and pre- and post- vaccination state anxiety will be assessed per participant written self-report to standardized survey questions.

Key facts

Study ID

NCT03533829

Run by

Duke University

People needed

30

Starts

2018-06-04

Expected to finish

2018-07-19

Last updated by the study team

2019-08-16

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 10 years through 17 years of age
• If 10 through 13 years of age, the subject must be receiving at least one vaccine delivered intramuscularly
• If 14 through 17 years of age, the subject must be receiving at least two injectable vaccines one of which must be delivered intramuscularly
• The parent/guardian must be willing and capable of providing written informed consent for the adolescent and the adolescent must be willing and capable of providing assent.
• The subject must be willing to stay for the completion of all study-related activities.
• Parent/guardian and adolescent must speak and read English by self-report

You may not qualify if…

• Receipt of investigational or experimental vaccine or medication within the previous two weeks
• Receipt of routine injectable medication
• Permanent indwelling venous catheter
• Blood drawn within the past hour or scheduled for a blood draw during the post-vaccination observation period
• Injection of medication during the past hour or scheduled for injection of medication during the observation period.
• Cold intolerance or cold urticaria
• Raynaud's phenomenon
• Sickle cell disease
• Inability to hear
• Significant visual impairment or blindness
• Febrile or acutely ill individuals
• Upper arm or shoulder pain or injury
• Adolescent or parent/Guardian is an immediate relative of study staff or an employee who is supervised by study staff.
• Any condition that would, in the opinion of the site investigator, place the participant at an unacceptable risk of injury or render the participant unable to meet the requirements of the protocol

Where it is running

• Centers for Disease Control and Prevention — Atlanta, Georgia, United States
• Duke University — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.